Dr. Bruce Riser is an R & D Pharmaceutical Leader / Biotech Founder, CEO/CSO and an expert in cardio-renal and fibrotic disease. After a career in pharmaceutical R&D and research in academic medicine, Dr. Riser founded BLR Bio. It's mission is to discover and develop first-in-class technology to diagnose, prevent and treat chronic disease and cancer, the two largest killers in the Western world. Its technology platform focuses on fibrosis in cardio-renal and liver disease, skin scarring and complications of diabetes, as well as cancer. Dr Riser has published more than 70 peer reviewed research articles and book chapters in the fields of cardiology, dermatology, nephrology, cancer, immunology, infectious disease, dialysis therapy, drug development, and diagnostics. He is the inventor of 20 plus issued patents.